Back to News
Market Impact: 0.2
Eli Lilly is about to report earnings. Here's what to expect
Source: CNBC
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Eli Lilly is slated to report third-quarter earnings and revenue, with Zepbound and Mounjaro expected to be key drivers. The article provides no reported results, estimates, or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
LLY0.30
More News
- Alphabet’s stock has worst day in over 20 years, dragging the S&P 500 to first loss in four days
- We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
- West Pharma earnings show it's more than a GLP-1 play. Why we see more upside
- Lilly’s obesity drug strength fuels record rally, Wall Street optimism
- Nasdaq futures slide as mixed Big Tech results test AI trade
- Stocks making the biggest moves midday: ADT, Alphabet, Caterpillar, Eli Lilly, Chipotle & more